VEGF and TSP1 levels correlate with prognosis in advanced non-small cell lung cancer. (Q44720064)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23463593%20AND%20SRC:MED&resulttype=core&format=json

25 February 2020

title

VEGF and TSP1 levels correlate with prognosis in advanced non-small cell lung cancer (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23463593%20AND%20SRC:MED&resulttype=core&format=json

25 February 2020

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23463593%20AND%20SRC:MED&resulttype=core&format=json

25 February 2020

author name string

T Fleitas

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23463593%20AND%20SRC:MED&resulttype=core&format=json

25 February 2020

V Martínez-Sales

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23463593%20AND%20SRC:MED&resulttype=core&format=json

25 February 2020

V Vila

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23463593%20AND%20SRC:MED&resulttype=core&format=json

25 February 2020

E Reganon

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23463593%20AND%20SRC:MED&resulttype=core&format=json

25 February 2020

D Mesado

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23463593%20AND%20SRC:MED&resulttype=core&format=json

25 February 2020

M Martín

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23463593%20AND%20SRC:MED&resulttype=core&format=json

25 February 2020

J Gómez-Codina

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23463593%20AND%20SRC:MED&resulttype=core&format=json

25 February 2020

J Montalar

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23463593%20AND%20SRC:MED&resulttype=core&format=json

25 February 2020

publication date

5 March 2013

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23463593%20AND%20SRC:MED&resulttype=core&format=json

Clinical and Translational Oncology

25 February 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23463593%20AND%20SRC:MED&resulttype=core&format=json

25 February 2020

volume

15

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23463593%20AND%20SRC:MED&resulttype=core&format=json

25 February 2020

issue

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23463593%20AND%20SRC:MED&resulttype=core&format=json

25 February 2020

page(s)

897-902

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23463593%20AND%20SRC:MED&resulttype=core&format=json

Angiogenesis and lung cancer: prognostic and therapeutic implications

25 February 2020

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS12094-013-1020-6

Role of the vascular endothelial growth factor pathway in tumor growth and angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-013-1020-6

Thrombospondin-1: multiple paths to inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-013-1020-6

Correlation of BRCA1, TXR1 and TSP1 mRNA expression with treatment outcome to docetaxel-based first-line chemotherapy in patients with advanced/metastatic non-small-cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-013-1020-6

New molecular targets in angiogenic vessels of glioblastoma tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-013-1020-6

Correlation between interleukin 6 production and tumor proliferation in non-small cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-013-1020-6

Human sialidase as a cancer marker

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-013-1020-6

Tissue factor and cell signalling in cancer progression and thrombosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-013-1020-6

Tissue-factor expression in human non-small-cell lung carcinoma measured by immunohistochemistry: correlation between tissue factor and angiogenesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-013-1020-6

Tissue factor expression in non-small cell lung cancer: relationship with vascular endothelial growth factor expression, microvascular density, and K-ras mutation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-013-1020-6

New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-013-1020-6

Atorvastatin neutralizes the up-regulation of thrombospondin-1 induced by thrombin in human umbilical vein endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-013-1020-6

Expression of tumor-derived vascular endothelial growth factor and its receptors is associated with outcome in early squamous cell carcinoma of the lung

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-013-1020-6

VEGF polymorphisms and survival in early-stage non-small-cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-013-1020-6

Vascular endothelial growth factor and its relationship to inflammatory mediators

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-013-1020-6

Circulating interleukin-6 level is a prognostic marker for survival in advanced nonsmall cell lung cancer patients treated with chemotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-013-1020-6

C-reactive protein, interleukin 6 and lung cancer risk: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-013-1020-6

Circulating markers of angiogenesis, inflammation, and coagulation in patients with glioblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-013-1020-6

Metabolic flux increases glycoprotein sialylation: implications for cell adhesion and cancer metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-013-1020-6

Inhibition of tissue factor signaling suppresses tumor growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-013-1020-6

Lung cancer associated venous thromboembolic disease: a comprehensive review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-013-1020-6

Significance of the correlation between the expression of interleukin 6 and clinical features in patients with non-small cell lung cancer

21 January 2018

1 reference

12 December 2020

[VEGF and survival of patients with lung cancer: a systematic literature review and meta-analysis]

1 reference

12 December 2020

Circulating angiogenic cytokines in patients with advanced non-small cell lung cancer: correlation with treatment response and survival

1 reference

12 December 2020

Correlation of serum biomarkers (TSA & LSA) and epithelial dysplasia in early diagnosis of oral precancer and oral cancer

1 reference

12 December 2020

Tissue factor expression pattern in human non-small cell lung cancer tissues indicate increased blood thrombogenicity and tumor metastasis

1 reference

12 December 2020

Predictive value of relative changes in serum total sialic acid level for response to neoadjuvant chemotherapy in patients with locally advanced breast carcinoma

1 reference

12 December 2020

Does postoperative serum interleukin-6 influence early recurrence after curative pulmonary resection of lung cancer?

1 reference

12 December 2020

Combined VEGF-A and VEGFR-2 concentrations in plasma: Diagnostic and prognostic implications in patients with advanced NSCLC

1 reference

12 December 2020